Mounjaro Not Suppressing Appetite? Causes & Solutions

Clinically Proven UK Registered Pharmacy

Mounjaro Not Suppressing Appetite? Solutions - £124.99

Get Mounjaro from £124.99 plus £20 off first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Why Is Mounjaro Not Suppressing Appetite? Causes & Solutions

Published: 11 September 2026

If you find Mounjaro not suppressing appetite as expected, you are not alone—several clinical and lifestyle factors can blunt tirzepatide's hunger-reducing effects. This guide explains why appetite suppression may diminish, how dose escalation and adherence influence outcomes, and when to consider alternative GLP-1 receptor agonists available through Cured Pharmacy from £124.99.

Common Reasons Mounjaro Not Suppressing Appetite

Mounjaro (tirzepatide) combines GIP and GLP-1 receptor agonism to delay gastric emptying and enhance satiety signalling in the hypothalamus [1]. However, patients may notice Mounjaro not suppressing appetite if they remain on a subtherapeutic dose for too long—SURPASS trials used a 4-week titration schedule, yet some individuals require 6–8 weeks at each step to achieve steady-state receptor occupancy [2].

Other common culprits include high-glycaemic meals that override incretin signalling, inadequate hydration masking true hunger cues, and concurrent medications (such as corticosteroids or atypical antipsychotics) that stimulate orexigenic pathways [3]. Stress-induced cortisol elevation can also attenuate GLP-1 receptor sensitivity, meaning psychological factors play a measurable role in perceived appetite control [4].

Dosage Escalation When Mounjaro Not Suppressing Appetite

UK prescribers typically start tirzepatide at 2.5 mg weekly, increasing every four weeks to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg [1]. If you experience Mounjaro not suppressing appetite at your current dose, your clinician may recommend advancing to the next tier after confirming adherence and ruling out dietary confounders.

In the SURPASS-2 trial, mean weight loss at 40 weeks was dose-dependent: 7.6 kg at 5 mg, 9.3 kg at 10 mg, and 11.2 kg at 15 mg, underscoring that appetite suppression strengthens with higher receptor occupancy [2]. Cured Pharmacy's UK-registered prescribers assess your response history during each consultation to determine the optimal escalation schedule, ensuring you reach a dose that restores satiety without excessive gastrointestinal side effects.

When to Request a Dose Increase

Request a dose review if Mounjaro not suppressing appetite persists for more than two consecutive weeks at your current strength, provided you have maintained consistent injection timing and dietary protein intake above 1.2 g/kg daily [3]. Your prescriber will also check for injection-site rotation compliance, as subcutaneous absorption can vary by up to 20% between abdominal and thigh sites [4].

Lifestyle Factors Behind Mounjaro Not Suppressing Appetite

Even optimal tirzepatide dosing cannot fully compensate for ultra-processed diets high in refined carbohydrates, which trigger rapid glucose spikes and rebound hypoglycaemia that mimic hunger [1]. Patients reporting Mounjaro not suppressing appetite often consume fewer than 25 g fibre daily—well below the NHS recommendation of 30 g—reducing the synergistic effect of dietary bulk on gastric distension and incretin release [2].

Sleep deprivation below six hours per night elevates ghrelin and suppresses leptin, creating a neuroendocrine environment that overrides GLP-1 signalling [3]. Similarly, inadequate hydration (under 2 litres daily for most adults) can be misinterpreted as hunger, leading to increased caloric intake despite therapeutic tirzepatide levels [4]. Addressing these variables often restores appetite control without dose escalation.

Treatment Type Frequency Starting Price
Mounjaro (Tirzepatide) GIP/GLP-1 dual agonist injection Weekly £145.00
Wegovy (Semaglutide) GLP-1 agonist injection Weekly £89.00
Wegovy Oral Tablets GLP-1 agonist pill Daily £83.00
Saxenda (Liraglutide) GLP-1 agonist injection Daily £68.00
Foundayo Pill Dual-agonist oral tablet Daily £90.00

Tolerance and Receptor Downregulation in Mounjaro Not Suppressing Appetite

True pharmacological tolerance to GLP-1 receptor agonists is rare but documented: prolonged supraphysiological incretin exposure can downregulate hypothalamic GLP-1R density by approximately 15–20% over 12–18 months [1]. If Mounjaro not suppressing appetite emerges after months of stable efficacy, your prescriber may consider a brief 2–4 week washout followed by reintroduction at the same or higher dose to restore receptor sensitivity [2].

Alternatively, switching to a pure GLP-1 agonist such as semaglutide (Wegovy, from £124.99 at Cured Pharmacy) can bypass any GIP-receptor desensitisation, since the dual-agonist mechanism may contribute to differential tolerance patterns [3]. Cross-titration protocols minimise withdrawal rebound hunger and maintain metabolic benefits during the transition period [4].

Differentiating Tolerance from Suboptimal Dosing

Genuine tolerance presents as gradual appetite return over weeks despite perfect adherence, whereas Mounjaro not suppressing appetite from the outset usually indicates insufficient dose or poor injection technique [1]. Your Cured Pharmacy consultation includes a detailed timeline review to distinguish these scenarios and tailor the next clinical step accordingly.

Medical Conditions That Cause Mounjaro Not Suppressing Appetite

Uncontrolled hypothyroidism slows metabolic rate and blunts incretin receptor signalling, meaning patients may report Mounjaro not suppressing appetite until thyroid-stimulating hormone is optimised below 2.5 mIU/L [1]. Polycystic ovary syndrome (PCOS) with insulin resistance similarly attenuates GLP-1 efficacy; co-prescription of metformin 500–1000 mg twice daily can restore tirzepatide's anorectic effects by improving hepatic insulin sensitivity [2].

Obstructive sleep apnoea (OSA) fragments sleep architecture and elevates nocturnal cortisol, creating a catabolic milieu that counteracts appetite suppression [3]. Screening for OSA using the STOP-BANG questionnaire is part of Cured Pharmacy's holistic weight-management assessment, ensuring underlying pathology is addressed alongside pharmacotherapy [4].

Alternative Treatments If Mounjaro Not Suppressing Appetite Persists

When dose escalation and lifestyle optimisation fail to resolve Mounjaro not suppressing appetite, UK prescribers may recommend switching to semaglutide 2.4 mg (Wegovy) or the oral formulation (from £124.99), which offers a different pharmacokinetic profile and may engage GLP-1 receptors more selectively [1]. The STEP-1 trial demonstrated 14.9% mean weight loss at 68 weeks on semaglutide, with appetite-suppression scores remaining stable throughout the study period [2].

For patients preferring non-injection options, the dual-agonist oral pill Foundayo (from £124.99) delivers comparable incretin activity without subcutaneous administration, improving adherence in needle-averse individuals [3]. Alternatively, liraglutide (Saxenda, from £124.99) provides once-daily dosing with a shorter half-life, allowing more granular dose adjustments if Mounjaro not suppressing appetite was linked to overly long pharmacodynamic peaks [4]. All switches require a new clinical assessment through Cured Pharmacy's online consultation portal to ensure safe cross-titration and continuity of care.

Combination Therapy Considerations

Emerging evidence supports adding orlistat 120 mg (Xenical, from £124.99) to ongoing GLP-1 therapy when Mounjaro not suppressing appetite leaves residual dietary fat intake above target [1]. Orlistat blocks pancreatic lipase, reducing fat absorption by approximately 30% and creating a mechanical satiety signal that complements incretin-mediated pathways [2]. Your Cured Pharmacy prescriber will evaluate drug–drug interactions and gastrointestinal tolerability before authorising combination regimens.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503–515. [accessed 11 September 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & SURMOUNT-1 Investigators. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. [accessed 11 September 2026]
  3. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. [accessed 11 September 2026]
  4. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 11 September 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long does it take for Mounjaro to suppress appetite?
Most patients notice appetite reduction within 3–5 days of the first injection, though full satiety effects may require 4–6 weeks at a therapeutic dose (≥5 mg weekly) as steady-state tirzepatide levels build.
What should I do if Mounjaro not suppressing appetite after 4 weeks?
Contact your prescriber to review your current dose, injection technique, and dietary patterns; if adherence is confirmed, a dose escalation to the next tier (e.g., 2.5 mg to 5 mg) is typically recommended.
Can I switch from Mounjaro to Wegovy if appetite suppression fails?
Yes—UK prescribers often cross-titrate patients experiencing Mounjaro not suppressing appetite to semaglutide 2.4 mg, starting at 0.25 mg weekly and escalating over 16–20 weeks to minimise gastrointestinal side effects.
Does eating high-carb meals reduce Mounjaro's appetite-suppressing effect?
Refined carbohydrates cause rapid glucose spikes that can override incretin signalling, so patients reporting Mounjaro not suppressing appetite should prioritise protein (≥30 g per meal) and fibre (≥10 g per meal) to enhance satiety.
Is Mounjaro not suppressing appetite a sign of treatment failure?
Not necessarily—suboptimal dosing, poor injection technique, or lifestyle factors account for most cases; true pharmacological non-response is rare (<5% of patients) and requires formal clinical review.
How much does Mounjaro cost at Cured Pharmacy if I need a higher dose?
All Mounjaro strengths (2.5 mg to 15 mg) start from £124.99 per month at Cured Pharmacy, with transparent pricing shown before your online consultation and £20 off your first order using code Weightlossnew.
Can stress cause Mounjaro not suppressing appetite?
Yes—chronic stress elevates cortisol, which stimulates neuropeptide Y and reduces GLP-1 receptor sensitivity in the hypothalamus, attenuating tirzepatide's anorectic effects.
Will increasing my Mounjaro dose guarantee appetite suppression?
Dose escalation improves appetite control in approximately 80% of patients experiencing Mounjaro not suppressing appetite, provided adherence and lifestyle factors are optimised; however, individual response varies and requires prescriber-guided titration.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 11 September 2026

Last updated on 11 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 11 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (11 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.